Invention Grant
US07666434B2 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same
有权
通过相同鉴定的HSV特异性T淋巴细胞和HSV抗原的快速,有效的纯化
- Patent Title: Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same
- Patent Title (中): 通过相同鉴定的HSV特异性T淋巴细胞和HSV抗原的快速,有效的纯化
-
Application No.: US12233280Application Date: 2008-09-18
-
Publication No.: US07666434B2Publication Date: 2010-02-23
- Inventor: David M. Koelle , Zhi Liu , Lawrence Corey
- Applicant: David M. Koelle , Zhi Liu , Lawrence Corey
- Applicant Address: US WA Seattle
- Assignee: University of Washington
- Current Assignee: University of Washington
- Current Assignee Address: US WA Seattle
- Agency: canady + lortz LLP
- Agent Karen S. Canady
- Main IPC: A61K39/245
- IPC: A61K39/245

Abstract:
Described is a method of identifying an immunologically active antigen of a virus that attacks skin, as well as a method of enriching a population of lymphocytes for T lymphocytes that are specific to a virus that attacks skin. Also provided are HSV antigens and epitopes that are useful for the prevention and treatment of HSV infection that have been identified via the methods of the invention. T-cells having specificity for antigens of the invention have demonstrated cytotoxic activity against cells loaded with virally-encoded peptide epitopes, and in many cases, against cells infected with HSV. The identification of immunogenic antigens responsible for T-cell specificity provides improved anti-viral therapeutic and prophylactic strategies. Compositions containing antigens or polynucleotides encoding antigens of the invention provide effectively targeted vaccines for prevention and treatment of HSV infection.
Public/Granted literature
- US20090148468A1 RAPID, EFFICIENT PURIFICATION OF HSV-SPECIFIC T-LYMPHOCYTES AND HSV ANTIGENS IDENTIFIED VIA SAME Public/Granted day:2009-06-11
Information query